Literature DB >> 32369589

Impaired Cellular Immune Responses During the First Week of Severe Acute Influenza Infection.

Jackson S Turner1, Tingting Lei1, Aaron J Schmitz1, Aaron Day2, José Alberto Choreño-Parra3,4, Luis Jiménez-Alvarez3, Alfredo Cruz-Lagunas3, Stacey L House2, Joaquín Zúñiga3,5, Ali H Ellebedy1, Philip A Mudd2.   

Abstract

BACKGROUND: Cellular immune responses are not well characterized during the initial days of acute symptomatic influenza infection.
METHODS: We developed a prospective cohort of human subjects with confirmed influenza illness of varying severity who presented within a week after symptom onset. We characterized lymphocyte and monocyte populations as well as antigen-specific CD8+ T-cell and B-cell responses from peripheral blood mononuclear cells using flow cytometry and enzyme-linked immunospot assays.
RESULTS: We recruited 68 influenza-infected individuals on average 3.5 days after the onset of symptoms. Three patients required mechanical ventilation. Influenza-specific CD8+ T-cell responses expanded before the appearance of plasmablast B cells. However, the influenza-specific CD8+ T-cell response was lower in infected subjects than responses seen in uninfected control subjects. Circulating populations of inflammatory monocytes were increased in most subjects compared with healthy controls. Inflammatory monocytes were significantly reduced in the 3 subjects requiring mechanical ventilation. Inflammatory monocytes were also reduced in a separate validation cohort of mechanically ventilated patients.
CONCLUSIONS: Antigen-specific CD8+ T cells respond early during acute influenza infection at magnitudes that are lower than responses seen in uninfected individuals. Circulating inflammatory monocytes increase during acute illness and low absolute numbers are associated with very severe disease.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  B cell; CD8+ T cell; Influenza; cellular immunity; illness severity; monocyte

Mesh:

Year:  2020        PMID: 32369589      PMCID: PMC7768688          DOI: 10.1093/infdis/jiaa226

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  27 in total

1.  Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines.

Authors:  Xiao-Song He; Tyson H Holmes; Caiqiu Zhang; Kutubuddin Mahmood; George W Kemble; David B Lewis; Cornelia L Dekker; Harry B Greenberg; Ann M Arvin
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

2.  Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus.

Authors:  K L Yap; G L Ada; I F McKenzie
Journal:  Nature       Date:  1978-05-18       Impact factor: 49.962

3.  Severe Influenza Is Characterized by Prolonged Immune Activation: Results From the SHIVERS Cohort Study.

Authors:  Sook-San Wong; Christine M Oshansky; Xi-Zhi J Guo; Jacqui Ralston; Timothy Wood; Ruth Seeds; Claire Newbern; Ben Waite; Gary Reynolds; Marc-Alain Widdowson; Q Sue Huang; Richard J Webby; Paul G Thomas
Journal:  J Infect Dis       Date:  2018-01-04       Impact factor: 5.226

4.  CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.

Authors:  Robin Daniel Abeles; Mark J McPhail; David Sowter; Charalambos G Antoniades; Nikhil Vergis; Godhev K Manakkat Vijay; Emmanuel Xystrakis; Wafa Khamri; Debbie L Shawcross; Yun Ma; Julia A Wendon; Diego Vergani
Journal:  Cytometry A       Date:  2012-07-26       Impact factor: 4.355

5.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Authors:  A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee
Journal:  Lancet       Date:  2017-12-14       Impact factor: 79.321

6.  Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load.

Authors:  Christine M Oshansky; Andrew J Gartland; Sook-San Wong; Trushar Jeevan; David Wang; Philippa L Roddam; Miguela A Caniza; Tomer Hertz; John P Devincenzo; Richard J Webby; Paul G Thomas
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

7.  Virus-specific antibody secreting cell, memory B-cell, and sero-antibody responses in the human influenza challenge model.

Authors:  Kuan-Ying Arthur Huang; Chris Ka-Fai Li; Elizabeth Clutterbuck; Cecilia Chui; Tom Wilkinson; Anthony Gilbert; John Oxford; Rob Lambkin-Williams; Tzou-Yien Lin; Andrew J McMichael; Xiao-Ning Xu
Journal:  J Infect Dis       Date:  2014-01-10       Impact factor: 5.226

8.  Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans.

Authors:  Patrick J Lillie; Tamara K Berthoud; Timothy J Powell; Teresa Lambe; Caitlin Mullarkey; Alexandra J Spencer; Matthew Hamill; Yanchun Peng; Marie-Eve Blais; Christopher J A Duncan; Susanne H Sheehy; Tom Havelock; Saul N Faust; Rob Lambkin Williams; Anthony Gilbert; John Oxford; Tao Dong; Adrian V S Hill; Sarah C Gilbert
Journal:  Clin Infect Dis       Date:  2012-03-22       Impact factor: 9.079

9.  Severe pandemic H1N1 2009 infection is associated with transient NK and T deficiency and aberrant CD8 responses.

Authors:  Annette Fox; Nguyen Minh Hoa Le; Peter Horby; H Rogier van Doorn; Vu Trung Nguyen; Hong Ha Nguyen; Trung Cap Nguyen; Dinh Phu Vu; Minh Ha Nguyen; Nguyen Thi Ngoc Diep; Vu Thi Ngoc Bich; Huong Tran Thi Kieu Huong; Walter R Taylor; Jeremy Farrar; Heiman Wertheim; Van Kinh Nguyen
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

10.  ISRE-Reporter Mouse Reveals High Basal and Induced Type I IFN Responses in Inflammatory Monocytes.

Authors:  Melissa B Uccellini; Adolfo García-Sastre
Journal:  Cell Rep       Date:  2018-12-04       Impact factor: 9.423

View more
  8 in total

1.  Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.

Authors: 
Journal:  Sci Immunol       Date:  2021-05-13

2.  Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm.

Authors:  Philip A Mudd; Jeremy Chase Crawford; Jackson S Turner; Aisha Souquette; Daniel Reynolds; Diane Bender; James P Bosanquet; Nitin J Anand; David A Striker; R Scott Martin; Adrianus C M Boon; Stacey L House; Kenneth E Remy; Richard S Hotchkiss; Rachel M Presti; Jane A O'Halloran; William G Powderly; Paul G Thomas; Ali H Ellebedy
Journal:  Sci Adv       Date:  2020-12-09       Impact factor: 14.136

3.  SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response.

Authors:  Jackson S Turner; Aaron Day; Wafaa B Alsoussi; Zhuoming Liu; Jane A O'Halloran; Rachel M Presti; Bruce K Patterson; Sean P J Whelan; Ali H Ellebedy; Philip A Mudd
Journal:  Front Immunol       Date:  2021-01-08       Impact factor: 7.561

4.  Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019.

Authors:  José Alberto Choreño-Parra; Luis Armando Jiménez-Álvarez; Gustavo Ramírez-Martínez; Alfredo Cruz-Lagunas; Mahima Thapa; Luis Alejandro Fernández-López; Martha Carnalla-Cortés; Eduardo M Choreño-Parra; Lourdes Mena-Hernández; Montserrat Sandoval-Vega; Erika Mariana Hernández-Montiel; Diana Lizzeth Hernández-García; Jazmín Ariadna Ramírez-Noyola; Cynthia Estefania Reyes-López; Andrea Domínguez-Faure; Guillermo Yamil Zamudio-López; Eduardo Márquez-García; Angélica Moncada-Morales; Criselda Mendoza-Milla; Diana Cervántes-Rosete; Marcela Muñoz-Torrico; Cesar Luna-Rivero; Ethel A García-Latorre; Parménides Guadarrama-Ortíz; Federico Ávila-Moreno; Guillermo Domínguez-Cherit; Tatiana Sofía Rodríguez-Reyna; Philip A Mudd; Carmen Margarita Hernández-Cárdenas; Shabaana A Khader; Joaquín Zúñiga
Journal:  J Infect Dis       Date:  2021-07-02       Impact factor: 5.226

5.  Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.

Authors:  Lina Ma; Sanjaya K Sahu; Marlene Cano; Vasanthan Kuppuswamy; Jamal Bajwa; Ja'Nia McPhatter; Alexander Pine; Matthew Meizlish; George Goshua; C-Hong Chang; Hanming Zhang; Christina Price; Parveen Bahel; Henry Rinder; Tingting Lei; Aaron Day; Daniel Reynolds; Xiaobo Wu; Rebecca Schriefer; Adriana M Rauseo; Charles W Goss; Jane A O'Halloran; Rachel M Presti; Alfred H Kim; Andrew E Gelman; Charles Dela Cruz; Alfred I Lee; Phillip Mudd; Hyung J Chun; John P Atkinson; Hrishikesh S Kulkarni
Journal:  bioRxiv       Date:  2021-02-23

6.  Comparing the Cytokine Storms of COVID-19 and Pandemic Influenza.

Authors:  Lynette Miroslava Pacheco-Hernández; Jazmín Ariadna Ramírez-Noyola; Itzel Alejandra Gómez-García; Sergio Ignacio-Cortés; Joaquín Zúñiga; José Alberto Choreño-Parra
Journal:  J Interferon Cytokine Res       Date:  2022-06-07       Impact factor: 3.657

7.  Comprehensive Immunologic Evaluation of Bronchoalveolar Lavage Samples from Human Patients with Moderate and Severe Seasonal Influenza and Severe COVID-19.

Authors:  Daniel Reynolds; Cristina Vazquez Guillamet; Aaron Day; Nicholas Borcherding; Rodrigo Vazquez Guillamet; José Alberto Choreño-Parra; Stacey L House; Jane A O'Halloran; Joaquín Zúñiga; Ali H Ellebedy; Derek E Byers; Philip A Mudd
Journal:  J Immunol       Date:  2021-08-04       Impact factor: 5.426

8.  Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy.

Authors:  Sierra M Barone; Alberta Ga Paul; Lyndsey M Muehling; Joanne A Lannigan; William W Kwok; Ronald B Turner; Judith A Woodfolk; Jonathan M Irish
Journal:  Elife       Date:  2021-08-05       Impact factor: 8.713

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.